首页|MiR-19a、miR-21和miR-29c在多发性骨髓瘤中的表达及临床意义

MiR-19a、miR-21和miR-29c在多发性骨髓瘤中的表达及临床意义

扫码查看
目的 探讨 microRNA-19a(miR-19a)、microRNA-21(miR-21)和 microRNA-29c(miR-29c)在多发性骨髓瘤(MM)中的相对表达水平及其对MM的临床意义.方法 选取2022年5月至2023年7月初诊MM患者的28例作为MM组,另外纳入无恶性血液疾病的健康供者(healthy donor,HD)9例作为对照.采用RT-PCR方法检测骨髓血浆和外周血清中miR-19a、miR-21和miR-29c相对表达水平,通过受试者工作曲线分析3种miRNA的诊断价值.调查入选者的临床资料包括血红蛋白、血清白蛋白、球蛋白、β2-微球蛋白、血清钙、血肌酐、乳酸脱氢酶、M蛋白、血沉、超敏C-反应蛋白、淋巴细胞亚群及临床分期与3种miRNA进行相关性分析.结果 MM组血清miR-19a、miR-21及miR-29c相对表达水平相对于HD组均低,而MM组骨髓miR-19a、miR-21及miR-29c表达水平相对于HD组均高,且MM组的骨髓表达水平比血清高(P<0.05).在MM组血清中,miR-19a、miR-21和miR-29c与超敏C-反应蛋白水平皆呈负相关[(r=-0.6220,P=0.0201)、(r=-0.6659,P=0.0113)、(r=-0.5429,P=0.0479)];miR-21 和 miR-29c 与球蛋白呈正相关[(r=0.5692,P=0.0366)、(r=0.5385,P=0.0500)],miR-21 和 miR-29c 与 M 蛋白呈正相关[(r=0.5938,P=0.0282)、(r=0.5497,P=0.0449)].除此之外,miR-21 与淋巴细胞亚群的 CD8+呈正相关性(r=0.6132,P=0.0224),与 CD4+/CD8+呈负相关(r=-0.5780,P=0.0333),miR-29c 与 CD8+呈正相关(r=0.5516,P=0.0438).受试者工作曲线分析血清miR-19a、miR-21及miR-29c的曲线下面积分别为0.8492、0.8889、0.8413,三者联合诊断MM的AUC为0.9683;骨髓miR-19a、miR-21及miR-29c的AUC分别为0.8788、0.8636、0.9091,无法计算骨髓中三者联合诊断MM的价值.结论 初诊MM患者的miR-19a、miR-21及miR-29c在血清中皆呈低表达,而在骨髓中皆呈高表达,并且不论是在血清还是骨髓中这3个miRNA都可以很好地区分MM和HD,但是血清3个miRNA联合诊断MM更有价值,并且具有成为MM预后生物标志物和治疗靶点的潜力.
Expressions of miR-19a,miR-21 and miR-29c in multiple myelomas and their clinical significances
Objective To investigate the expression levels of microRNA-19a(miR-19a),microRNA-21(miR-21),and microRNA-29c(miR-29c)in multiple myelomas(MM)and their clinical significances.Methods Between May 2022 and July 2023,28 patients initially diagnosed with MM were included in the MM group,while 9 healthy donors(HD)without malignant hematological diseases were included in the control group.Expression levels of miR-19a,miR-21,and miR-29c in bone marrow plasma and peripheral serum were detected in MM patients by reverse transcription-polymerase chain reaction(RT-PCR).The diagnostic value of the three miRNAs was analyzed using the receiver operating characteristic(ROC)curves.Correlations of hemoglobin,serum albumin,globulin,β2-microglobulin,serum calcium,serum creatinine,lactate dehydrogenase,M protein,erythrocyte sedimentation rate(ESR),hypersensitive C-reactive protein(hs-CRP),lymphocyte subsets,and clinical stages of MM with the three miRNAs were analyzed using Spearman's correlation.Results Serum miR-19a,miR-21,and miR-29c levels were significantly lower in the MM group than the HD group,while those in the bone marrow were significantly higher in the MM group(P<0.05).MiR-19a,miR-21 and miR-29c were all negatively correlated with hs-CRP levels(r=-0.6220,P=0.0201;r=-0.6659,P=0.0113;r=-0.5429,P=0.0479.There was a positive correlation of miR-21 and miR-29c with globulin(r=0.5692,P=0.0366;r=0.5385,P=0.0500),and a positive correlation of miR-21 and miR-29c with M protein(r=0.5938,P=0.0282;r=0.5497,P=0.0449).In addition,miR-21 was positively correlated with CD+8 lymphocyte subsets(r=0.6132,P=0.0224)and negatively correlated with CD4+/CD8+(r=-0.5780,P=0.0333).MiR-29c was positively correlated with CD8+(r=0.5516,P=0.0438).ROC curve analysis showed that the area under the curve(AUC)of serum miR-19a,miR-21 and miR-29c was 0.8492,0.8889 and 0.8413,respectively,and the AUC of the three combined to diagnose MM was 0.9683.AUC of miR-19a,miR-21 and miR-29c in bone marrow was 0.8788,0.8636 and 0.9091,respectively.The AUC of the three combined in the diagnosis of MM in bone marrow could not be calculated.Conclusion MiR-19a,miR-21,and miR-29c levels are low in the serum and high in the bone marrow of newly diagnosed MM patients.These three miRNAs can effectively differentiate MM from HD in both the serum and bone marrow.However,combining serum levels of these miRNAs is more valuable for diagnosing MM,serving as a prognostic biomarker and therapeutic target for MM.

multiple myelomamicroRNA-19amicroRNA-21microRNA-29cclinical significance

韩泽宇、张晓阳、锁静、吕鸿雁、藏美蓉、孙丽霞、张金巧、宋晓宁

展开 >

050000 石家庄市,河北医科大学第三医院血液科

多发性骨髓瘤 微小RNA-19a 微小RNA-21 微小RNA-29c 临床意义

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(24)